Timothy K. Andrews, General Counsel & Secretary at Sienna Biopharmaceuticals, Inc. (SNNA), bought 15,000 shares at $15.00 ($225K) on 2017-08-01, disclosed to the SEC on 2017-08-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.